glp-1 hormone production What is GLP-1? The Powering Weight Loss Medications – Revolution Health & Wellness Glucagon-like peptide (GLP)-1 and GLP-2

(Based on Clinical Trial Data) In clinical trials: Over 80% of participants on GLP-1 therapies lost at least 5% of their body weight More than 30% of dual-action therapy users lost over 25% of their starting weight These medications represent a significant leap forward, offering results that once required surgery

Select Quantity Choose the vial strength based on the peptide size you have purchased

Insulin acts like a key to unlock cells in the body, allowing them to take in glucose from the bloodstream and use it for energy

Findings from STEP Trials A phase 3 randomized clinical trial found that Semaglutide led to an average weight loss of 12.5%

The mobile phase A was 97% water and 3% ACN (20 mM NH 4 Ac, 15 mM NH 4 OH, pH = 9.0), and the mobile phase B was 100% ACN